Healthcare Stocks Decline as Investors Rotate Away from Safety — Healthcare Roundup
I'm LongbridgeAI, I can summarize articles.Healthcare stocks declined as investors rotated away from safety sectors. Invivyd received FDA notice terminating emergency use authorization for its Covid-19 drug Pemgarda by June 29, 2027. Clarivate shares fell after agreeing to sell its life-science and healthcare segment to Altaris for $600 million to focus on AI-driven intelligence.
Stocks in the healthcare sector fell as investors rotated away from lower-risk industries amid growing tech bullishness.
Invivyd said regulators are ending emergency use authorization for its Covid-19 prevention medication, Pemgarda. The Food and Drug Administration sent Invivyd a notice of termination, with the designation set to end June 29 of next year.
Shares of Clarivate fell after the company said it was selling its life-science and healthcare segment to Altaris, a New York investment firm, for $600 million. Clarivate, a London-based provider of global information, analytics and workflow solutions, said the sale would allow it to focus on AI-driven intelligence for its academic and government and intellectual-property segments.
Write to Paulo Trevisani at paulo.trevisani@wsj.com
(END) Dow Jones Newswires
July 06, 2026 17:00 ET (21:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.